Type of cancer | Number (Relative frequency %) | |||
---|---|---|---|---|
Planning CTA | Surveillance CTA | Total | ||
Non-visible | Missed | |||
Bladder | 6 (22.2) | 0 | 3 (23) | 9 (17.6) |
Bone | 1 (3.7) | 1 (9.1) | 1 (7.7) | 3 (5.9) |
Carcinoid | 1 (3.7) | 0 | 0 | 1 (1.9) |
Colorectal | 7 (25.9) | 2 (18.2) | 1 (7.7) | 10 (19.6) |
Gallbladder | 0 | 1 (9.1) | 0 | 1 (1.9) |
Gastric | 1 (3.7) | 1 (9.1) | 0 | 2 (3.9) |
Liver | 0 | 0 | 3 (23) | 3 (5.9) |
Lung | 4 (14.8) | 3 (27.2) | 1 (7.7) | 8 (15.7) |
Non Hodgkin’s Lymphoma | 3 (11.1) | 1 (9.1) | 1 (7.7) | 5 (9.8) |
Pancreatic | 0 | 1 (9.1) | 1 (7.7) | 2 (3.9) |
Prostate | 2 (7.4) | 1 (9.1) | 1 (7.7) | 4 (7.8) |
Renal | 2 (7.4) | 0 | 1 (7.7) | 3 (5.9) |
Total | 21 | 11 | 13 | 51 |